From January 1, 2024 to March 31, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 854,166 shares, representing 1.57% for $10.18 million under the buyback announced on August 4, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.35 USD | +12.90% | +19.71% | -20.63% |
09/07 | Evercore ISI Trims Price Target on Health Catalyst to $8 From $9, Maintains Outperform Rating | MT |
01/07 | Health Catalyst, Inc.(NasdaqGS:HCAT) added to Russell 3000E Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.63% | 384M | |
-14.65% | 61.67B | |
+4.02% | 59.85B | |
+4.25% | 54.56B | |
+7.74% | 43.29B | |
+7.21% | 38.53B | |
+117.14% | 28.93B | |
-8.96% | 28.59B | |
+5.21% | 22.1B | |
+25.08% | 14.74B |
- Stock Market
- Equities
- HCAT Stock
- News Health Catalyst, Inc.
- Tranche Update on Health Catalyst, Inc.'s Equity Buyback Plan announced on August 4, 2022.